Methotrexate and psoriasis: Consensus conference

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages 1179-

  Kalb, Robert E ^a   Strober, Bruce ^b   Weinstein, Gerald ^c   Lebwohl, Mark ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; FOLIC ACID; METHOTREXATE;

BLOOD TOXICITY; CLINICAL PROTOCOL; CONSENSUS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG USE; HUMAN; LETTER; LIVER BIOPSY; LIVER TOXICITY; MEDICAL EXPERT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR;

BIOPSY; DERMATOLOGIC AGENTS; HUMANS; LIVER; METHOTREXATE; PRACTICE GUIDELINES AS TOPIC; PSORIASIS;

EID: 79956117449     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.10.041     Document Type: Letter

References (3)

1. Roenigk HH Jr, Auerbach R, Maibach HI. Methotrexate guidelines 2009? J Am Acad Dermatol 2010;63:344-5.
2. Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2009;60:824-37.
3. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009;61: 451-485.